Abstract
BackgroundDrug costs constitute a major part of health expenditure in Turkey. Among drug classes, antineoplastics are the most expensive. Another attempt at cost savings in antineoplastic drugs could be achieved...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Hospital Pharmacy: Science and Practice
Paper Title
Journal
Date
